On the molecular level, neurotoxic β-amyloid peptides (Aβ) are deposited in the brains of AD patients after β- and γ-secretase cleavage of the amyloid precursor protein (APP) (Pohland et al., 2018; Hampel et al., 2021). This evidence concerns the gene APP and Alzheimer disease.